Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong · Delayed Price · Currency is HKD 14.86
+0.12 (0.81%)
Sep 30, 2026, 4:08 PM HKT
Sinopharm Group Market Cap
Sinopharm Group has a market cap or net worth of 46.37 billion as of October 1, 2026. Its market cap has decreased by -19.02% in one year.
Market Cap
46.37B
Enterprise Value
163.46B
Revenue
660.27B
Ranking
n/a
PE Ratio
5.67
Stock Price
14.86
ChartMarket Cap Chart
Since September 23, 2009, Sinopharm Group's market cap has increased from 40.42B to 46.37B, an increase of 14.72%. That is a compound annual growth rate of 0.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 46.37B | -23.56% |
| Dec 31, 2025 | 60.67B | -8.73% |
| Dec 31, 2024 | 66.47B | 4.16% |
| Dec 29, 2023 | 63.82B | 3.07% |
| Dec 30, 2022 | 61.91B | 16.98% |
| Dec 31, 2021 | 52.93B | -10.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Guanze Medical Information Industry (Holding) | 2.72B |
| 160 Health International | 1.17B |
| Sipai Health Technology | 1.10B |
| ETHK Labs | 697.87M |
| Charmacy Pharmaceutical | 593.46M |
| China Health Group | 423.08M |
| ClouDr Group | 303.49M |
| Sinco Pharmaceuticals Holdings | 284.60M |